Osteopathic Physician CME

Stay on top of your game with the StatPearls Physician Unlimited CME programs. With 6,046 activities, StatPearls is the largest CME provider in the world. These Pub-Med Indexed articles are categorized into 162 specialty areas which lets you better access activities that will make the biggest impact on your practice. One subscription allows access to all the activities, including all state-requirements.

Pricing Options

• 6 Month subscription: All 6,339 CME Activities – $249 per 6 months
• Annual subscription: All 6,339 CME Activities – $349 per 1 year
• Lifetime: All 6,339 CME Activities + Access to Board Reviews Forever – $1999

Notable disparities are present both with regard to individuals in the healthcare profession as well as in the delivery of healthcare to the patient population. Increasing awareness of the importance of diversity, equity, and inclusion is important for expanding access to high quality healthcare.

This presentation will be designed to introduce the audience to an important national level dialogue on the concepts of diversity, equity, and inclusion. Additionally, this topic will be tailored to understanding how DEI relates to healthcare practice and note specific steps the profession is taking to improve DEI at an organizational level.

Every 7 minutes in our country, a person dies from a drug overdose, while a child is also born approximately every 30 minutes dependent on opioids. How do we as healthcare professionals offer non-stigmatic patient care and contribute to the progress of society in the right direction? Substance use disorder (addiction) is likened to an iceberg or a weed, in that the issues underneath the surface are typically even more complicated than what is viewed from the surface. Addiction spans hundreds of substances of abuse highlighted by stimulants (cocaine and methamphetamine), cannabis (plant, synthetics, and extracts), and opioids (heroin, fentanyl, and carfentanyl). As one can recall with the substance of ethyl alcohol (i.e. beer, wine, and hard liquor), a substance may never actually chemically change, yet can move across legal classifications of substances, leaving all healthcare professionals in need of knowledge on all substances of abuse. Opioid use disorder (opioid addiction) is combated with the medication-assisted treatments (MAT) of naltrexone, methadone, and buprenorphine, while opioid overdose respiratory depression is reversed with naloxone. Over the course of this activity, we will aim for “higher” education on all of these dynamic aspects. Unlike opioids, this activity is sure to open your eyes and possibly even elevate your blood pressure and/or heart rate!!!

With eight categories of HIV meds now available, healthcare professionals need to be up to date about these therapies. Whether using regimens from 20 years ago, or the newest drugs healthcare professionals need to be monitoring adherence to those regimens. By providing data from the San Francisco Study to show the needs for 95% adherence. This Florida-approved course will also describe the advantages and disadvantages of each category of drugs, as well as those individual drugs.

This course is designed for healthcare professionals and those in allied professions who may come into contact with and be called upon to intervene on behalf of victims of human trafficking within the scope of their practice.

According to the 2015 National Survey on Drug Use and Health, approximately 3.8 million people (1.4% of those ages 12 or older) reported misusing prescription pain relievers, while another 329,000 people reported using heroin. Within the same year, 52,404 lethal overdoses took place, making drug overdose the leading cause of accidental death within the United States. Stancliff et al estimated that as of 2012, approximately 80% of people dependent on heroin or prescription opioids were not engaged in any treatment and many in treatment do not use the most effective medication-assisted treatments available to them.

Despite recent increased awareness of opioid use disorder (OUD) and efforts to improve access to care, several barriers to treatment still exist, including financial, geographic, regulatory, and social. In 2012, only 2.2% of physicians in the United States obtained waivers to prescribe buprenorphine for the treatment of OUD. Of those who received waivers, 41.6% were psychiatrists. This may be perceived as a potential barrier to OUD treatment as patients are often resistant to referrals to psychiatric and/or addiction clinics given the stigmas commonly surrounding addiction and mental health. Furthermore, physicians with waivers were found to practice primarily in urban settings, leaving a large portion of the rural population without access to buprenorphine treatment.

With all this in mind, education is needed in regards to current and emerging treatment options for OUD available to multiple patient populations. Also, with the deaths due to drug overdoses still elevated, education on how to recognize and reverse an opioid overdose is needed.

This presentation will address the above needs by discussing the science behind opioid use disorder as well as reflect upon current statistics associated with its impact on the United States. During the discussion, opioid overdose risks will be discussed and participants will be able to practice recognizing key symptoms of an overdose situation. Steps of using naloxone will be discussed and connected to how to appropriately seek out treatment for maintenance of opioid use disorder. Finally, new buprenorphine products and the potential role of naltrexone will be applied to this stigmatized population.

This course provides 2 AMA PRA Category 1 Credit for license renewal and talks about the pharmacology, adverse effects, dosage, and administration of FDA-approved treatments for acute pain like nonopioid analgesics, adjuvant pain medications, migraine medicines, Tramadol/Celecoxib (Seglentis), Bupivacaine/Meloxicam (Zynrelef), IV Meloxicam (Anjeso), and Benzhydrocodone/Acetaminophen (Apadaz).

This course provides 1 AMA PRA Category 1 Credit for license renewal. Vaginal infections can cause pain and discomfort. Without treatment, they may lead to complications that can adversely affect a person’s health. From bacterial vaginosis to sexually transmitted infections, learn more about a few of the most common types of vaginal infections and symptoms here. This activity provides recommendations for the management of most sexually transmitted infections (STIs) other than HIV and viral hepatitis and FDA-approved treatments for bacterial vaginosis like Tinidazole (Tindamax) and Secnidazole (Solosec).

This course discusses the different FDA-approved antibiotics for the treatment of complicated urinary tract infections (UTIs). It talks about the pharmacology, clinical studies, adverse effects, dosage, and administration of Meropenem/Vaborbactam (Vabomere), Plazomicin (Zemdri), and Cefiderocol (Fetroja) for proper use.

This video activity focuses on ways to help early detection of breast cancer by learning the risk factors, the different screening and diagnostic modalities and guidelines to what kind of screening is needed, and most importantly, when should screening begin.